Aβ25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil

Journal of Neurophysiology

Volumn 89, Issue 6, 2003, Pages 3061-3069

  Freir, D B ^a   Costello, D A ^a   Herron, C E ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DILTIAZEM; VERAPAMIL;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; CALCIUM TRANSPORT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; LONG TERM POTENTIATION; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; DILTIAZEM; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; LONG-TERM DEPRESSION (PHYSIOLOGY); LONG-TERM POTENTIATION; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION; VERAPAMIL;

EID: 0037603598     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00992.2002     Document Type: Article

References (43)

1. 2+-channel hypothesis for neuronal death in Alzheimer disease. Mol Cell Biochem 140: 119-125, 1994.
2. Bhatia R, Lin H, and Lal R. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AβP channel-mediated cellular toxicity. FASEB J 9: 1233-1243, 2000.
3. Bliss TV and Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39, 1993.
4. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, and Hsiao KK. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 3: 271-276, 1999.
5. Chen QS, Kagan BL, Hirakura Y, and Xie CW. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res 60: 65-72, 2000.
6. Coon AL, Wallace DR, Mactutus CF, and Booze RM. L-type calcium channels in the hippocampus and cerebellum of Alzheimer's disease brain tissue. Neurobiol Aging 20: 597-603, 1999.
7. Costello D and Herron CE. Interaction of L-type calcium channel blockers and Aβ [25-35] on long term potentiation in the hippocampal CA1 in vitro. Eur J Physiology 443S: P28-7, 2002.
8. Cullen WK, Suh YH, Anwyl R, and Rowan MJ. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. Neuroreport 8: 3213-3217, 1997.
9. Ekinci FJ, Malik KU, and Shea TB. Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates betaamyloid-induced neurodegeneration. J Biol Chem 274: 30322-30327, 1999.
10. Freir DB, Holscher C, and Herron CE. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J Neurophysiol 85: 708-713, 2001.
11. 2+ channel blockers verapamil and diltiazem attenuate Aβ-induced impairment of LTP in area CA1 of the anaesthetised rat. J Physiol 531P:107P, 2001.
12. 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo. J Neurophysiol 89: 2917-2922, 2003.
13. 2+ channels. J Neurochem 77: 953-956, 2001.
14. Grover LM and Teyler TJ. Two components of long-term potentiation induced by different patterns of afferent activation. Nature 347: 477-479, 1990.
15. Hirrlinger J, Konig J, and Dringen R. Expression of mRNAs of multidrug resistence proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J Neurochem 82: 716-719, 2002.
16. Holdright D. Calcium-channel antagonists in cardiovascular disease, Br J Hosp Med 57: 552-556, 1997.
17. Huang HM, Ou HC, and Hsieh SJ. Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons. Life Sci 66: 1879-1892, 2000.
18. Jonker JW, Wagenaar E, van Deemter L, Gottschlich R, Bender HM, Dasenbrock J, and Schinkel AH. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug. Br J Pharmacol 127: 43-50, 1999.
19. Kapur A, Yeckel MF, Gray R, and Johnston D. L-type calcium channels are required for one form of hippocampal mossy fibre LTP. J Neurophysiol 79: 2181-2190, 1998.
20. Kelley SR, Kamal TJ, and Molitch ME. Mechanism of verapamil calcium channel blockade-induced hyperprolactinemia. Am J Physiol 270: E96-E100, 1996.
21. Lam FC, Liu R, Lu P, Shapiro AB, Renoir J-M, Sharom FJ, and Reiner PB. β-Amyloid efflux mediated by p-glycoprotein. J Neurochem 76: 1121-1128, 2001.
22. Lippa CF, Nee LE, Mori H, and St. George-Hyslop P. Aβ-42 deposition precedes other changes in PS-1 Alzheimer's disease. Lancet 352: 1117-1118, 1998.
23. Lynch G, Larson J, Kelso S, Barrionuevo G, and Schottler F. Intracellular injections of EGTA block induction of hippocampal long-term potentiation. Nature 305: 719-721, 1983.
24. 2+ channel activity by beta-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1β. J Biol Chem 275: 4713-4718, 2000.
25. Malenka RC. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78: 535-538, 1994.
26. Malenka RC, Kauer JA, Zucker RS, and Nicoll RA. Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science 242: 81-84, 1988.
27. Mattson MP, Partin J and Begley JG. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res, 807: 167-76, 1998.
28. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur J Pharmacol 352: 189-197, 1998.
29. Morgan SL and Teyler TJ. VDCCs and NMDARs underlie two forms of LTP in CA1 hippocampus in vivo. J Neurophysiol 82: 736-740, 1999.
30. Morris RG, Garrud P, Rawlins JN, and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297: 681-683, 1982.
31. Pajeva IK and Wiese M. Pharmacophore model of drugs involved in Pglycoprotein multidrug resistance: explanation of structural variety (hypothesis). J Med Chem 45: 5671-5686, 2002.
32. Saleshando G and O'Connor JJ. SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of beta-amyloid on long-term potentiation in the rat hippocampus. Neurosci Lett 288: 119-122, 2000.
33. Selkoe DJ. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275: 630-631, 1997.
34. Silei V, Fabrizi C, Venturini G, Salmona M, Bugiani O, Tagliavini F, and Lauro GM. Activation of microglial cells by PrP and beta-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels. Brain Res 818: 168-170, 1999.
35. Stephan A, Laroche S, and Davis S. Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 21: 5703-5714, 2001.
36. 2+ channels, Trends Pharmacol Sci 19: 108-115, 1998.
37. 2+ channels: a possible involvement of free radicals. J Neurochem 68: 265-271, 1997.
38. Vogelgesang S, Cascorbi I, Schroder E, Pahnke J, Kroemer H, Siegmund W, Kunert-Keil C, Walker LC, and Warzok R. Deposition of Alzheimer's beta-amyloid is inversely correlated with p-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 12: 535-541, 2002.
39. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, and Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539, 2002.
40. Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, Viola KL, Klein WL, Stine WB, Krafft GA, and Trommer BL. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924: 133-140, 2002.
41. Weisskopf MG, Bauer EP, and Le Doux JE. L-type voltage-gated calcium channels mediate NMDA-independent associative long-term potentiation at thalamic input synapses to the amygdala. J. Neurosci 19: 10512-10519, 1999.
42. Yan XZ, Qiao JT, Dou Y, and Qiao ZD. Beta-amyloid peptide fragment 31-35 induces apoptosis in cultured cortical neurons. Neuroscience 92: 177-184, 1999.
43. Yankner BA, Duffy LK, and Kirschner DA. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250: 279-282, 1990.